                             STATE OF WEST VIRGINIA

                          SUPREME COURT OF APPEALS
                                                                                   FILED
RONALD J. JONES,                                                               December 17, 2013
                                                                            RORY L. PERRY II, CLERK
Claimant Below, Petitioner                                                SUPREME COURT OF APPEALS
                                                                              OF WEST VIRGINIA

vs.)   No. 12-0558 (BOR Appeal No. 2046523)
                   (Claim No. 990028571)

INCO ALLOYS INTERNATIONAL, INC.,
Employer Below, Respondent


                             MEMORANDUM DECISION
       Petitioner Ronald J. Jones, by Edwin H. Pancake, his attorney, appeals the decision of the
West Virginia Workers’ Compensation Board of Review. Inco Alloys International, Inc., by
Steven K. Wellman, its attorney, filed a timely response.

       This appeal arises from the Board of Review’s Final Order dated April 3, 2012, in which
the Board affirmed a September 26, 2011, Order of the Workers’ Compensation Office of
Judges. In its Order, the Office of Judges affirmed the claims administrator’s February 4, 2011,
decision denying Mr. Jones’s request for the following medications: Opana, Neurontin,
Tramadol, and Lodine. The Court has carefully reviewed the records, written arguments, and
appendices contained in the briefs, and the case is mature for consideration.

       This Court has considered the parties’ briefs and the record on appeal. The facts and legal
arguments are adequately presented, and the decisional process would not be significantly aided
by oral argument. Upon consideration of the standard of review, the briefs, and the record
presented, the Court finds no substantial question of law and no prejudicial error. For these
reasons, a memorandum decision is appropriate under Rule 21 of the Rules of Appellate
Procedure.

        Mr. Jones worked for Inco Alloys International, Inc. as a metal tester/furnace operator.
On August 25, 1998, he suffered an injury to his back while breaking up slag metal. The claim
was held compensable for the diagnosis of lumbago. On January 19, 2009, Dr. Caraway stated
that he was treating Mr. Jones with Opana, Neurontin, Tramadol, and Lodine, and that it seems
to control his pain reasonably well. Dr. Guberman concluded on April 26, 2009, that Mr. Jones
had reached maximum medical improvement. The claims administrator denied Mr. Jones’s
request for the following medications: Opana, Neurontin, Tramadol, and Lodine.


                                                1
       The Office of Judges affirmed the claims administrator’s decision and held that there was
no error in denying the medications Opana, Neurontin, Tramadol, and Lodine. Mr. Jones
disagrees and asserts that he has shown by medical evidence that the medications were
reasonably required to treat his compensable injury.

       The Office of Judges determined that the medications Neurontin and Lodine were
properly denied in the claims administrator’s decisions dated April 15, 2005, and October 12,
2005. The April 15, 2005, decision was not appealed, but the October 12, 2005, decision was
appealed and affirmed by the Office of Judges, the Board of Review, and this Court. The Office
of Judges found that the medication Opana was also properly denied in a claims administrator’s
decision dated November 19, 2009, pursuant to West Virginia Code of State Rules § 85-20­
53.14a that does not allow prescribing schedule II drugs on an outpatient basis for longer than
two weeks after the initial injury or following a subsequent surgery.

        The Office of Judges concluded that the medication Tramadol was properly denied by the
claims administrator’s decision dated February 4, 2011, but that the claims administrator
incorrectly cited West Virginia Code of State Rules § 85-20-53.b (2006) instead of West
Virginia Code of State Rules § 85-20-53.14b (2006). This section prohibits prescribing schedule
III drugs on an outpatient basis for longer than six weeks after initial injury, or following a
subsequent operative procedure. The Office of Judges found this injury was over thirteen years
old. The Office of Judges held that Mr. Jones’s request for the medications Opana, Neurontin,
Tramadol, and Lodine were properly denied. The Board of Review reached the same reasoned
conclusions in its decision of April 3, 2012. We agree with the reasoning and conclusions of the
Board of Review.

        For the foregoing reasons, we find that the decision of the Board of Review is not in clear
violation of any constitutional or statutory provision, nor is it clearly the result of erroneous
conclusions of law, nor is it based upon a material misstatement or mischaracterization of the
evidentiary record. Therefore, the decision of the Board of Review is affirmed.


                                                                                        Affirmed.

ISSUED: December 17, 2013

CONCURRED IN BY:
Chief Justice Brent D. Benjamin
Justice Robin J. Davis
Justice Allen H. Loughry II

DISSENTING:
Justice Margaret L. Workman
Justice Menis E. Ketchum


                                                2
